...
tvgn-img

Tevogen Bio Holdings Inc, Common Stock

TVGN

NMQ

$1.02

+$0.02

(2%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$175.05M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
2.8571
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.40M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-1.03
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.26 L
$21.09 H
$1.02

About Tevogen Bio Holdings Inc, Common Stock

Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTVGNSectorS&P500
1-Week Return-4.67%-3.72%-0.05%
1-Month Return-23.31%-1.85%2.75%
3-Month Return123.19%-11.4%7.4%
6-Month Return17.24%-4.41%10.47%
1-Year Return-78.66%4.13%27.57%

Financials

Jun '22Jun '23Jun '24
Total Revenue---[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Cost of Revenue---[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit---[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Margin---[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Operating Expenses4.62M953.08K2.27M[{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":20.64,"profit":true},{"date":"2024-06-30","value":49.24,"profit":true}]
Operating Income(4.62M)(13.72M)(8.84K)[{"date":"2022-06-30","value":-461846200,"profit":false},{"date":"2023-06-30","value":-1372406400,"profit":false},{"date":"2024-06-30","value":-884303,"profit":false}]
Total Non-Operating Income/Expense(16.19M)4.42M(314.51K)[{"date":"2022-06-30","value":-366.13,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-7.11,"profit":false}]
Pre-Tax Income(15.60M)4.41M(67.33K)[{"date":"2022-06-30","value":-353.8,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-1.53,"profit":false}]
Income Taxes(9.78M)(230.82K)255.87K[{"date":"2022-06-30","value":-3822.82,"profit":false},{"date":"2023-06-30","value":-90.21,"profit":false},{"date":"2024-06-30","value":100,"profit":true}]
Income After Taxes(5.82M)4.64M(323.19K)[{"date":"2022-06-30","value":-125.36,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-6.97,"profit":false}]
Income From Continuous Operations(15.60M)4.41M(67.33K)[{"date":"2022-06-30","value":-353.8,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-1.53,"profit":false}]
Income From Discontinued Operations---[{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(15.60M)4.41M(67.33K)[{"date":"2022-06-30","value":-353.8,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-1.53,"profit":false}]
EPS (Diluted)0.000.12(0.37)[{"date":"2022-06-30","value":3.17,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":-310.58,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TVGN
Cash Ratio 0.22
Current Ratio 0.34

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TVGN
ROA (LTM) -593.01%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TVGN
Debt Ratio Lower is generally better. Negative is bad. 2.44
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.44

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TVGN
Trailing PE 2.86
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 0.00
EV/Ebitda 3.50

FAQs

What is Tevogen Bio Holdings Inc share price today?

Tevogen Bio Holdings Inc (TVGN) share price today is $1.02

Can Indians buy Tevogen Bio Holdings Inc shares?

Yes, Indians can buy shares of Tevogen Bio Holdings Inc (TVGN) on Vested. To buy Tevogen Bio Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TVGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tevogen Bio Holdings Inc be purchased?

Yes, you can purchase fractional shares of Tevogen Bio Holdings Inc (TVGN) via the Vested app. You can start investing in Tevogen Bio Holdings Inc (TVGN) with a minimum investment of $1.

How to invest in Tevogen Bio Holdings Inc shares from India?

You can invest in shares of Tevogen Bio Holdings Inc (TVGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in TVGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tevogen Bio Holdings Inc shares
What is Tevogen Bio Holdings Inc 52-week high and low stock price?

The 52-week high price of Tevogen Bio Holdings Inc (TVGN) is $21.09. The 52-week low price of Tevogen Bio Holdings Inc (TVGN) is $0.26.

What is Tevogen Bio Holdings Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tevogen Bio Holdings Inc (TVGN) is 2.8571

What is Tevogen Bio Holdings Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tevogen Bio Holdings Inc (TVGN) is 0.00

What is Tevogen Bio Holdings Inc dividend yield?

The dividend yield of Tevogen Bio Holdings Inc (TVGN) is 0.00%

What is the Market Cap of Tevogen Bio Holdings Inc?

The market capitalization of Tevogen Bio Holdings Inc (TVGN) is $175.05M

What is Tevogen Bio Holdings Inc’s stock symbol?

The stock symbol (or ticker) of Tevogen Bio Holdings Inc is TVGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top